# Pharmakologisches cognitive enhancement



## Topics 


## Block overview


## Objectives üìç

## Materials




## Kurzzusammenfassung

<iframe src="https://docs.google.com/document/d/10YIqojOguAA9vTN5fYh5JY8wz24ZFzQh/edit?usp=sharing&ouid=108122900663902144880&rtpof=true&sd=true" frameborder="0" width="600" height="1070" allowfullscreen="true" mozallowfullscreen="true" webkitallowfullscreen="true"></iframe>

## Literature

Sahakian, B. J., & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology, 25(2), 197-204.

Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223), 702-705.

Kapur, A. (2020). Is methylphenidate beneficial and safe in pharmacological cognitive enhancement?. CNS drugs, 34(10), 1045-1062.


Paolo Busard√≤, F., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016). From clinical application to cognitive enhancement: the example of methylphenidate. Current neuropharmacology, 14(1), 17-27.

Battleday, R. M., & Brem, A. K. (2016). Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 26(2), 391.


Barbey, A. K., Karama, S., & Haier, R. J. (Eds.). (2021). The Cambridge handbook of intelligence and cognitive neuroscience. Cambridge University Press.
- Chapter 18: Enhancing Cognition


## Project related work


## tasks for subsequent meeting/Homework



## optional/reading/further materials


## additional resources


## Literature

